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donor bacteremia. We describe a novel mechanism for 
transmission through direct contamination of a thoracic 
vascular graft that was removed at the time of organ 
retrieval. The use of a contaminated innominate artery 
jump graft for pancreas transplantation resulted in 
vascular anastomotic infection in multiple recipients 
from a non-bacteremic donor colonized with Pseudo- 
monas aeruginosa. 
Methods: Patient data was collected by chart review 
from the donor and the kidney, kidney-pancreas, heart, 
lung and liver recipients at 4 separate transplant centers. 
Isolates of P aeruginosa were tested for relatedness by 
molecular typing using pulsed-field gel electrophoresis 
(PFGE). 
Results: The donor was a previously healthy 25 year old 
man who died of a closed head injury. He was intubated 
for 24h prior to organ retrieval. The donor’s routine 
tracheal suction cultures were positive for P aeruginosa 
but all blood cultures were negative. Organs were 
retrieved for lung, liver, kidney-pancreas, kidney, and 
heart transplantation. The donor trachea was transected 
and the intrathoracic organs were removed first. A 
second transplant team retrieved the innominate artery 
graft, which was in close proximity to the open end of 
the donor trachea, and the intra-abdominal organs. The 
kidney-pancreas recipient had Pseudomonas bacteremia 
and rupture of the anastomosis between the innominate 
artery and native iliac artery 48h post-transplant; the 
pancreas was subsequently lost. The renal transplant 
recipient lost his graft from a renal artery anastomotic 
rupture 9 days after transplant. The liver transplant 
recipient died from a ruptured mycotic aneurysm of the 
hepatic artery associated with P aeruginosa bacteremia. 
The lung transplant recipient developed P aeruginosa 
pneumonia but no endovascular infection. The heart 
recipient had an uncomplicated post-operative course. 
All 5 Pseudomonas isolates had the same antibiogram 
and were found to be identical by molecular typing using 
PFGE. 
Conclusion: We conclude that donors may transmit 
bacterial infections to multiple recipients by mech- 
anisms other than donor bacteremia. This highlights the 
importance of obtaining donor cultures from multiple 
sites. In this outbreak, the spillage of tracheal secretions 
from the transected trachea directly contaminated the 
innominate artery graft, which resulted in cross- 
contamination of the intraabdominal organs. Although 
donor tracheal cultures are commonly positive, careful 
consideration should be given to antimicrobial treat- 
ment of recipients when a Gram-negative organism is 
isolated. 
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Aim: To evaluate our strategy of FLU P only in HSCT 
R with non-Candida krusei colonization (COL). 
Materials and Methods: A prospective cohort study 
from July 1996 to December 2001; 289 consecutive 
HSCT R were included to detect Candida spp from oro- 
pharynx and stool (high risk pts) by weekly surveillance 
cultures, taken from the beginning of chemotherapy 
until neutropenia was resolved and were plated onto 
selective Chrom-agar plates. Only the pts with non- 
Ckrusei COL received FLU 200 mg/day until engraft- 
ment or empirical amphotericin B initiation; pts under- 
going antifungal prophylaxis or treatment at the time of 
inclusion were excluded. Demographic characteristics 
were: n pts: 289, mean age: 33.8 (O-70) female: 169 
(58%), hematological diseases: 197 (68%), solid tumors: 
89 (32%) others: 3 (1%) autologous (AU): 203 (70%) 
allogeneic (AL): 86 (30%) mean engraftment days: 12.8 
(3-48). 
Results: There were no differences in the frequency of 
MD IF1 in the compared populations 
l C albicans was the most frequent species isolated in 
COL pts and caused 2 IF1 
l Candida krusei was isolated in 6 (3.4%) COL pts, 3 
selected during FLU P 
l Two Ckrusei caused 2 (1.4%) IF1 and were isolated 
after 9 and 14 days of FLU P 
l There was one mortality related to MD IF1 
Conclusions: (1) There were significantly more 
neutropenia days and empirical amphotericin B usage in 
COL population. (2) FLU P only in non-Candida krusei 
COL pts was safe and cost-effective, avoiding toxicity 
and emergence of resistant strains. 
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We performed a survey to elicit risk factors for CMV 
retinitis (CMVR) after blood stem cell transplantation 
(SCT). A total of 24 cases have been reported from 13 
EBMT centres. In the risk factor analysis, 18 patients 
were included. A control group of 2467 patients was 
selected who were transplanted at the contributing 
centres during the study period who had a follow up 
time of more than one month. The median time from 
transplantation to diagnosis of CMVR was 160 days 
